Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years ; volume:13 ; number:1 ; day:24 ; month:7 ; year:2013 ; pages:1-13 ; date:12.2013
BMC infectious diseases ; 13, Heft 1 (24.7.2013), 1-13, 12.2013
- Urheber
-
Kieninger, Dorothee
- Beteiligte Personen und Organisationen
-
Sheldon, Eric
Lin, Wen-Yuan
Yu, Chong-Jen
Bayas, José M.
Gabor, Julian J.
Esen, Meral
Fernandez Roure, Jose Luis
Narejos Perez, Silvia
Alvarez Sanchez, Carmen
Feng, Yang
Claeys, Carine
Peeters, Mathieu
Innis, Bruce L.
Jain, Varsha
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-13-343
- URN
-
urn:nbn:de:1111-2016050228581
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kieninger, Dorothee
- Sheldon, Eric
- Lin, Wen-Yuan
- Yu, Chong-Jen
- Bayas, José M.
- Gabor, Julian J.
- Esen, Meral
- Fernandez Roure, Jose Luis
- Narejos Perez, Silvia
- Alvarez Sanchez, Carmen
- Feng, Yang
- Claeys, Carine
- Peeters, Mathieu
- Innis, Bruce L.
- Jain, Varsha
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015
Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients
Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza among Chinese elderly: a test-negative design
HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy
PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine
Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine
Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015
Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients
Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza among Chinese elderly: a test-negative design
HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy
PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine
Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine
Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015
Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients
Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza among Chinese elderly: a test-negative design
HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy
PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine
Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine